A Healthier Future for Everyone, Everywhere

At J&J MedTech, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.

Our Global Impact

280M patients' lives touched globally*

Nearly 52M patients and consumers globally use J&J Vision products

Nearly 60,000 employees worldwide

Selling products in virtually all countries

$27B in 2021 sales

24 institutes on 5 continents training >125,000 HCPs globally

Using Our Breadth and Scale To Impact Global Healthcare Needs

32%

32% of the global burden of disease can be attributed to surgically treatable conditions

250M

Osteoarthritis affects 250M people globally, and is a leading cause of disability²

1.8M

Lung cancer is the most commonly diagnosed cancer worldwide, responsible for 1.8M deaths in 2018³

1 in 4

1 in 4 adults over the age of 40 is at risk of developing AFib⁴

13.7M

13.7M people experience their first stroke every year⁵

2.2B

Globally, 2.2 billion people are visually impaired

Reimagining the Way Healthcare Is Delivered, and Helping People Live Longer, Healthier Lives

Our Focus Areas Include:

Doctors' office with physician showing two patients' image on iPad

Orthopaedics

We provide one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve while delivering clinical and economic value to healthcare systems worldwide. Specialties include joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine.

Depuy Synthes

Surgery

We deliver innovative surgical technologies and solutions to surgeons and healthcare professionals around the world to effectively treat some of the world’s most prevalent conditions such as obesity, cardiovascular disease, and cancer.

Ethicon

Patient and healthcare professional laughing

Cardiovascular, Stroke & Specialty Solutions

Our portfolio encompasses a range of innovative business segments that support professionals with tools for neurovascular care, heart rhythm disorders, ear, nose and throat treatment, and breast reconstruction.

Acclarent
Cerenovus
Biosense Webster
Mentor

Physician at work -smiling while at desktop computer

Eye Health

We bring together cutting-edge insights, science, technology, and people to encourage eye care professionals and patients to proactively protect, correct, and enhance healthy sight for life. Our products and services address needs at every stage – from the pediatric to aging eye – in a patient’s lifetime.

J&J Vision

Continually Focusing on Elevating the Standard of Care

Innovating at the Forefront of Science and Technology

Patient having telehealth appointment with physician

Developing Connected Products and Solutions Across the Entire Patient Journey

Leveraging Data and Insights with the Goal of Lowering Costs, Increasing Access and Improving Outcomes

We are building leading-edge capabilities in digital surgery positioning us for success over the long term. Our vision is to shape a future where medical intervention is smarter, less invasive and more personalized.

Committed to Improving the Communities Where We Live and Work

At the community level, the Johnson & Johnson MedTech companies work with physician, patient and community partners to provide life-enhancing, life-saving services to people in need.

American Heart Association

Operation Smile

Sight for Kids

HCP Cure Blindness

Save the Children

Susan G. Komen^®

Meet the Leaders

Ashley McEvoy

Executive Vice President
Worldwide Chairman
Johnson & Johnson MedTech

Vladimir Makatsaria

Company Group Chairman
Ethicon

Aldo Denti

Company Group Chairman
DePuy Synthes

Shlomi Nachman

Company Group Chairman
CSS and J&J Vision

Hani Abouhalka

Company Group Chairman
Robotics & Digital Solutions

Mark Benson

Worldwide VP
Supply Chain

Liz Blackwood

Chief Quality Officer
VP, Quality & Compliance

Lisa Blair Davis

Global Head HR

Luly de Samper

International VP
LATAM

Stephanie Hartgrove

Global Leader
Communication & Public Affairs

Larry Jones

SVP & Group CIO

Celine Martin

Company Group Chairman
Cardiovascular & Specialty
Solutions Group

Peter Menziuso

Company Group Chairman
J&J Vision

Susan Morano

VP, Business Development
and Strategic Operations

Tim Schmid

Company Group Chairman
APAC

Peter Schulam

Global Head, Medical Affairs,
Clinical Affairs and
Pre-Clinical Research

Peter Shen

Global Head R&D

Kurt Van den Bosch

Chief Financial Officer
Group Finance

Ashley Watson

General Counsel

Gavin Wood

Company Group Chairman
EMEA

References

The Lancet Global Surgery Commission, 2015; The Lancet, November 2014
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-1759.
The Cancer Atlas. Lung Cancer. https://canceratlas.cancer.org/the-burden/lung-cancer/
Lloyd-Jones, Donald M., et al. “Lifetime risk for development of atrial fbrillation: the Framingham Heart Study.” Circulation110.9 (2004):1042-1046.
Learn about stroke. World Stroke Organization. www.world-stroke.org https://www.world-stroke.org/world-stroke-day-campaign/why-stroke-matters/learnabout-stroke.
The Challenge of Providing Spectacles in the Developing World. Brien Holden, PhD DSc OAM, et al; Community Eye Health, 2000

*Data are an approximate number according to Johnson & Johnson global internal unit volume across platforms.

The third party trademarks used herein are the trademarks of their respective owners.

173141-210407 DSUS